atrial fibrillation requiring Transcatheter Aortic Valve Replacement (TAVR)
Protocol: STUDY00002538
Full Title
Watchman for patients with Atrial Fibrillation undergoing transcatheter Aortic Valve Replacement
Description
This study enrolls people with atrial fibrillation undergoing transcatheter aortic valve replacement (TAVR). The purpose of the study is to look at the safety and effectiveness of the WATCHMAN device procedure when it is done at the same time with the TAVR procedure.
Please contact us to learn more about what is involved in this study.
Compensation is not available for this study.

Technical Description

To evaluate the safety and effectiveness of the left atrial appendage occlusion with WATCHMAN Device in prevention of stroke and bleeding in patients with atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR).
Compensation: No
Eligibility
Adults ages 18+.
Diagnosed as having atrial fibrillation (AF or AFib) and aortic stenosis (AS) requiring a Transcatheter Aortic Valve Replacement (TAVR).
Age Group: Adults
Principal Investigator: VIJAY IYER
ClinicalTrials.gov: Open Study
Contact(s)
COURTNEY BISHOP
cabishop@buffalo.edu
Want to Learn More?
Enrollment Update

Due to COVID-19, new enrollment in research studies will be greatly limited. If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry. View the guidance for research participants for additional information.

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.